Health Trials

CD34+ Stem Cells

1

Review clinical trials related to CD34+ Stem Cells. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Role of CD34+ Stem Cells in the Pathogenesis of Takotsubo Syndrome

The underlying mechanisms of microvascular dysfunction in Takotsubo cardiomyopathy remain incompletely understood. As CD34+ cells are essential to coronary microvascular homeostasis we will investigate the potential association between CD34+ cell count and changes in left ventricular function in patients with Takotsubo cardiomyopathy at baseline and 6-month follow-up.

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Medical Centre LjubljanaUpdated: May 22, 2026Locations: 1
Eligibility criteria

Minimum age 18 years [+2]

Patients under the age of 18 years [+12]

Read more